Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

September 2, 2019 updated by: Cui Xulei

Ultrasound-guided Continous Quadratus Lumborum Block: Effect on Acute Pain and Quality of Recovery After Hepatic Surgery With Right Subcostal Incision

This prospective, randomized study, control study aims to compare the analgesic effect, opioids consumption, quality of recovery, length of hospital stay and et al. between unilateral continuous quadratus lumborum block (QLB) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100730
        • Xulei CUI

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 18-70 yrs
  • American Society of Anesthesiologists physical statusⅠ-Ⅲ
  • Undergo hepatectomy with right J-shape subcostal incision
  • Informed consent

Exclusion Criteria:

  • A known allergy to the drugs being used
  • Coagulopathy, on anticoagulants
  • Analgesics intake, history of substance abuse
  • Participating in the investigation of another experimental agent
  • Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Continuous QLB+postoperative IPCA
Single-injection of QLB (quadratus lumborum block) is given preoperatively followed with continuous infusion+ postoperative IPCA (intravenous patient control analgesia)
The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scan
Inject local anesthetics in between quadratus lumborum and psoas major muscle with catheter insertion and continuous local infusion
Other Names:
  • Inject local anesthetics in between quadratus lumborum and psoas major muscle with catheter insertion and continuous local infusion
  • 0.6ml/kg 0.5% ropivacaine with 1:200,000 adrenaline given immediately after the correct position of the tip of the needle has been verified.
  • followed with 0.2% ropivacaine infusion at a rate of 0.125ml/kg/h given through the catheter inserted in between the quadratus lumborum muscle and psoas major muscle.
Bolus: 1-2mg, lock time: 10min, 1h limitation: 5-10mg. without background infusion.
Active Comparator: IPCA
Postoperative IPCA (intravenous patient control analgesia) is given alone
Bolus: 1-2mg, lock time: 10min, 1h limitation: 5-10mg. without background infusion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cumulative morphine consumption
Time Frame: at 24 postoperative hours
at 24 postoperative hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative hospital length of stay
Time Frame: Up to 6 weeks
Up to 6 weeks
The pain scores determined by the numeric rating scale (NRS, 0-10)
Time Frame: At 0, 2,4, 8, 12, 24 ,48,72 hours and 7 day after the surgery
At 0, 2,4, 8, 12, 24 ,48,72 hours and 7 day after the surgery
Nausea and Vomiting score
Time Frame: At 0, 2,4, 8, 12, 24 and 48 hours after the surgery
At 0, 2,4, 8, 12, 24 and 48 hours after the surgery
Pruritus score
Time Frame: At 0, 2,4, 8, 12, 24 and 48 hours after the surgery
At 0, 2,4, 8, 12, 24 and 48 hours after the surgery
Ambulation time
Time Frame: within the 7 days after surgery
within the 7 days after surgery
Time of recovery of bowl movement
Time Frame: within the 7 days after surgery
within the 7 days after surgery
Quality of recovery
Time Frame: 3 days and 7 days after surgery
use the self-assessment 11 item QoR scale to assess the patient's recovery quality
3 days and 7 days after surgery
Patient satisfaction with anesthesia
Time Frame: 48 hours after surgery
use the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia
48 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Yuguang Huang, MD., Peking Union Medical College Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2018

Primary Completion (Actual)

May 29, 2019

Study Completion (Actual)

May 29, 2019

Study Registration Dates

First Submitted

September 22, 2016

First Submitted That Met QC Criteria

September 23, 2016

First Posted (Estimate)

September 26, 2016

Study Record Updates

Last Update Posted (Actual)

September 4, 2019

Last Update Submitted That Met QC Criteria

September 2, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on Philip CX50 Ultrasound Scanner

Subscribe